<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 11 Apr 2026 17:38:41 -0400--><rss version="2.0">
    <channel>
        <title>Ensysce Biosciences, Inc. (ENSC) In The News</title>
        <link>https://ir.ensysce.com/news/in-the-news/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/ensysce/files/theme/images/logo-sm.png</url>
                <title>Ensysce Biosciences, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.prnewswire.com/news-releases/ensysce-biosciences-ceo-dr-lynn-kirkpatrick-and-creighton-universitys-dr-neel-pathak-discuss-the-opioid-crisis-and-next-generation-opioids-302390154.html</link>
                <pubDate>Mon, 03 Mar 25 00:00:00 -0500</pubDate>
                <guid>https://www.prnewswire.com/news-releases/ensysce-biosciences-ceo-dr-lynn-kirkpatrick-and-creighton-universitys-dr-neel-pathak-discuss-the-opioid-crisis-and-next-generation-opioids-302390154.html</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[In Conversation With: Dr Lynn Kirkpatrick, Ensysce Biosciences]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.ddw-online.com/in-conversation-with-dr-lynn-kirkpatrick-ceo-of-ensysce-biosciences-28124-202401/</link>
                <pubDate>Mon, 29 Jan 24 00:00:00 -0500</pubDate>
                <guid>https://www.ddw-online.com/in-conversation-with-dr-lynn-kirkpatrick-ceo-of-ensysce-biosciences-28124-202401/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach]]></title>
                <description><![CDATA[]]></description>
                <link>https://xtalks.com/navigating-the-future-of-pain-management-ensysce-biosciences-innovative-approach-3655/</link>
                <pubDate>Wed, 20 Dec 23 00:00:00 -0500</pubDate>
                <guid>https://xtalks.com/navigating-the-future-of-pain-management-ensysce-biosciences-innovative-approach-3655/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.proactiveinvestors.com/companies/news/1017909/revolutionizing-pain-relief-the-next-generation-of-opioids-interview-with-ensysce-biosciences-ceo-1017909.html</link>
                <pubDate>Wed, 14 Jun 23 00:00:00 -0400</pubDate>
                <guid>https://www.proactiveinvestors.com/companies/news/1017909/revolutionizing-pain-relief-the-next-generation-of-opioids-interview-with-ensysce-biosciences-ceo-1017909.html</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[As the White House attempts to expand overdose treatment,  Ensysce is planning to provide pain relief with overdose protection.]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.ensysce.com/news/in-the-news/detail/18626/as-the-white-house-attempts-to-expand-overdose-treatment</link>
                <pubDate>Wed, 17 May 23 00:00:00 -0400</pubDate>
                <guid>https://ir.ensysce.com/news/in-the-news/detail/18626/as-the-white-house-attempts-to-expand-overdose-treatment</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Ensysce Biosciences: A Solution to the Opioid Crisis?]]></title>
                <description><![CDATA[]]></description>
                <link>https://podcasts.apple.com/us/podcast/ensysce-biosciences-a-solution-to-the-opioid-crisis/id1505127731?i=1000598265820</link>
                <pubDate>Mon, 06 Feb 23 00:00:00 -0500</pubDate>
                <guid>https://podcasts.apple.com/us/podcast/ensysce-biosciences-a-solution-to-the-opioid-crisis/id1505127731?i=1000598265820</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[As We Enter “the Most Dangerous Time of the Year”, a Solution to Prescription Opioid Overdose may be in Sight]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.biospace.com/article/as-we-enter-the-most-dangerous-time-of-the-year-a-solution-to-prescription-opioid-overdose-may-be-in-sight/</link>
                <pubDate>Thu, 15 Dec 22 00:00:00 -0500</pubDate>
                <guid>https://www.biospace.com/article/as-we-enter-the-most-dangerous-time-of-the-year-a-solution-to-prescription-opioid-overdose-may-be-in-sight/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dr. Vince Clinical Research Announces Dosing of Ensysce's PF614 Compound in Human Abuse Potential Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://financialpost.com/globe-newswire/dr-vince-clinical-research-announces-dosing-of-ensysces-pf614-compound-in-human-abuse-potential-trial</link>
                <pubDate>Wed, 09 Nov 22 00:00:00 -0500</pubDate>
                <guid>https://financialpost.com/globe-newswire/dr-vince-clinical-research-announces-dosing-of-ensysces-pf614-compound-in-human-abuse-potential-trial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Women in Pharma: Ensysce Biosciences’ CEO aims to combat prescription drug abuse]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.drugdiscoverytrends.com/women-in-pharma-ensysce-biosciences-ceo-aims-to-combat-prescription-drug-abuse/</link>
                <pubDate>Mon, 26 Sep 22 00:00:00 -0400</pubDate>
                <guid>https://www.drugdiscoverytrends.com/women-in-pharma-ensysce-biosciences-ceo-aims-to-combat-prescription-drug-abuse/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Ensysce Featured on Benzinga All Access]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.youtube.com/watch?v=I3_lmqUiH8Q</link>
                <pubDate>Fri, 23 Sep 22 00:00:00 -0400</pubDate>
                <guid>https://www.youtube.com/watch?v=I3_lmqUiH8Q</guid>
                                                                            </item>
            </channel>
</rss>